MORRISTOWN, N.J., Aug. 16 /PRNewswire/ -- Defined Health, a leading business development strategy consultancy to pharma, biotech and healthcare investment senior executives, is pleased to announce additions to consulting staff and the promotions of Ginger S. Johnson, PhD and Nabil Mouline, MBA.
Ginger S. Johnson has been promoted to the position of Vice President. Dr. Johnson joined Defined Health in 2001. She leads Defined Health’s opportunity identification and CNS practices, and is responsible for corporate development initiatives.
Nabil Mouline has been promoted to Director of Consulting Services. Mr. Mouline manages Defined Health’s consulting group and forecasting unit, and participates in commercial evaluations of developmental compounds and therapeutic area strategy projects.
Thomas Thuene, PhD, MsSc has joined Defined Health as a Senior Consultant. Dr. Thuene previously held positions at Bayer Pharmaceuticals and Accenture, and has a wide range of pharmaceutical industry experience in scientific research, research operations and consulting. Dr. Thuene earned a MsSc at the University of Hamburg and the EMBL Hamburg, and a PhD in physics at the Technical University of Munich and the EMBL Grenoble. Dr. Thuene’s post-doctoral research in the field of protein mobility and molecular docking was conducted with Prof. G. Petsko at Brandeis University.
Cameron S. Dunnan has joined Defined Health as a Consultant. In this capacity, he will participate in commercial, clinical and scientific assessments of early-stage development assets in a variety of therapeutic areas. Mr. Dunnan has worked previously as a consultant with the Monitor Group, ISO Healthcare Consulting and Bogart Delafield Ferrier, and has held positions at J&J PRD LLC and Ortho-McNeil Pharmaceutical. Mr. Dunnan received his BS in Biochemistry from Brown University and an MBA from Rutgers Business School.
About Defined Health
Founded 22 years ago, Defined Health (http://www.definedhealth.com) is a leading biopharmaceutical business development strategy consulting firm whose clients include pharma, emerging and specialty pharma, biotech, and healthcare investment companies. The firm’s consultants hold advanced degrees in science, medicine and business, and have industry experience in business development, commercial evaluation, finance, licensing, drug discovery and R&D, and its clients include more than half of the world’s top 20 pharmaceutical companies. Defined Health is the sponsor of Therapeutic Insight 2006, a global strategy conference to be held April 24 -- 26, 2006 at the Ritz-Carlton, Boston.
For information: http://www.definedhealth.com Contact: Ginny E. Llobell Vice President Defined Health 973-292-5001 ginnyllobell@definedhealth.com
Defined Health
CONTACT: Ginny E. Llobell, Vice President of Defined Health,+1-973-292-5001, ginnyllobell@definedhealth.com
Web site: http://www.definedhealth.com/
